Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> Leukemia/Lymphoma/Myeloma

The value of 18F-FDG PET (/CT) in the patients with post-transplant lymphoproliferative disorder (PTLD) (ID 1465)

Session Name
POP (Poster Oral Presentations) Ups
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> Leukemia/Lymphoma/Myeloma

Previous Eposter
Randomized Phase 3 Trial of 68Ga-PSMA-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]: Study Protocol (ID 1449)

Next Eposters
A semi-automated method to separate tumor from physiological uptakes on FDG PET-CT for efficient generation of training data targeting deep learning (ID 1527)
TEMPO Compounds for PET/MRI Imaging of Oxidative Stress (ID 1480)
Prognostic value of automatically acquired biomarkers using artificial intelligence in 18F-Choline PET/CT in high-risk prostate cancer. (ID 1458)
Relationships between noise-equivalent count rates for extended NEMA NU 2-like scatter phantoms and a human subject scanned using the EXPLORER total-body PET scanner (ID 1533)
Automated construction of patient-specific computational models using convolutional networks for conceptus dose estimation in pregnant patients (ID 1529)
Impact of [18F]PSMA-1007 uptake in prostate cancer using different peptide concentrations: preclinical PET/CT study in mice. (ID 1453)
Pictorial Review of the 18F-FDG PET/CT Manifestations of Erdheim-Chester Disease (ID 1489)
Optimization and Standardization of Gastric Emptying: Getting the Most Out of this Valuable Diagnostic Tool (ID 1486)
On Enhancing Monte-Carlo Scatter Correction for Y90 Bremsstrahlung SPECT using Guided Filtering (ID 1531)
The correlation of in vivo tau with amyloid beta, hypometabolism, and cortical atrophy in chronic TBI subjects. (ID 1506)